Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - etoposide phosphate 1159mg equivalent to 1000 mg etoposide (includes 2% overage);   - powder for injection - 1000 mg - active: etoposide phosphate 1159mg equivalent to 1000 mg etoposide (includes 2% overage)   excipient: dextran 40 nitrogen sodium citrate dihydrate

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - etoposide phosphate 119.3mg equivalent to 100 mg etoposide (includes 5% overage);   - powder for injection - 100 mg - active: etoposide phosphate 119.3mg equivalent to 100 mg etoposide (includes 5% overage)   excipient: dextran 40 nitrogen sodium citrate dihydrate - in combination with other approved chemotherapeutic agents as first-line treatment in patients with small cell lung cancer.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - etoposide phosphate 579.4mg equivalent to 500 mg etoposide (includes 2% overage);   - powder for injection - 500 mg - active: etoposide phosphate 579.4mg equivalent to 500 mg etoposide (includes 2% overage)   excipient: dextran 40 nitrogen sodium citrate dihydrate - in combination with other approved chemotherapeutic agents as first-line treatment in patients with small cell lung cancer.

Canadá - inglés - Health Canada

teva canada limited - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents

Canadá - inglés - Health Canada

fresenius kabi canada ltd - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents

Canadá - inglés - Health Canada

strides pharma canada inc - etoposide - solution - 20mg - etoposide 20mg - antineoplastic agents

Australia - inglés - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - etoposide, quantity: 50 mg - capsule - excipient ingredients: sodium propyl hydroxybenzoate; glycerol; sodium ethyl hydroxybenzoate; citric acid; iron oxide red; gelatin; titanium dioxide; macrogol 400; purified water - 1 - small cell carcinoma of the lung 2 - acute monocytic and myelomonocytic leukaemia 3 - hodgkins disease 4 - non-hodgkins lymphonia indications as at 5 october 2000: in the treatment of: 1. small cell carcinoma of the lung. 2. acute monocytic and myelomonocytic leukaemia. 3. hodgkin's disease. 4. non-hodgkin's lymphoma.

Estados Unidos - inglés - NLM (National Library of Medicine)

teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - etoposide - solution for infusion - 20mg/1ml

Armenia - inglés - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare limited - etoposide - concentrate for solution for infusion - 20mg/ml